Oxford Global's inaugural Drug Discovery USA Congress - second round of hot topics announced

After the continued success of the European Drug Discovery Summit Series, Oxford Global are pleased to announce their inaugural Drug Discovery USA Congress, taking place in Boston on the 21st & 22nd October 2014.

This congress brings together over 150 senior experts to discuss recent developments in drug discovery and medicinal chemistry, with topics including screening technology, drug design, assay development, external innovation access, computational chemistry and discovery informatics.

Following the release of the first round of Hot Topics in June, Oxford Global are pleased to announce the latest Hot Topics, including:

Finding Differentiated Hits & MoA's using Pfizer's Compound Screening File
Confirmed speaker: John Mathias, Senior Director - Cystic Fibrosis Program Leader, Pfizer

Predictive Sciences: A Transformational Opportunity for Pharmaceutical Research and Development
Confirmed speaker: Chris Waller, Director Cheminformatics, Merck

Supporting Innovation Through Industry/Academic Partnerships
Confirmed speaker: Debra Peattie, Life Science Director & Entrepreneur-in-Residence, GSK

Autophagic Target Discovery Using High Content Imaging and siRNA Screening
Confirmed speaker: Christopher Hale, Scientist, Discovery Technologies, Amgen

Open Innovation Efforts Across The Spectrum Of Drug Discovery
Confirmed speaker: Craig Wegner, Executive Director, Translational Science, Emerging Innovations Unit, Scientific Partnering & Alliances, AstraZeneca

Our speaker programmes have been carefully researched, ensuring delegates are exposed to the highest level of expertise. Speakers so far include:

  • Gregory Adam, Associate Principal Scientist, Screening and Protein Sciences, Merck Research Labs
  • Kevin Burgess, Rachal Professor of Chemistry, Texas A&M University
  • Russell C. Petter, Vice President, Chemistry, Celgene
  • Michael Clark, Associate Director of Chemistry, Vertex Pharmaceuticals, Inc
  • Chris De Savi, Associate Director, Medicinal Chemistry Cancer Research, AstraZeneca
  • Mohanraj Dhanabal, Senior Principal Investigator, Discovery Technologies, Molecular Pharmacology, EMD Serono

To find out who else will be speaking at this two-day event, visit http://www.discoveryusa-congress.com/speakers/

Register your interest today to hear over 40 outstanding case studies and presentations, across four interactive streams:

  • R&D Models For The Future
  • Screening & Assays: Enabling Technologies
  • Discovery Chemistry & Drug Design
  • Supporting Innovation: Translational Approaches & Informatics Tools

To view this two-day event in more detail, download the conference programme here.

Registration has been open for a couple of months and is proving popular. To obtain the last remaining discounted places, please contact Danielle Dalby on +44(0) 1865 248455 or email d.dalby@oxfordglobal.co.uk for more information.